| Trial ID: | L0937 |
| Source ID: | NCT01650181
|
| Associated Drug: |
Metformin
|
| Title: |
Biochemical and Echosonographic Impacts Using Siliphos-Selenium-Methionine-Alpha Lipoic Acid + Metformin Versus Metformin in Patients With Fatty Liver and Steatohepatitis
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Liver Disease
|
| Interventions: |
Drug: Metformin;Dietary Supplement: Siliphos+ Selenium - Methionine + Alpha Lipoic Acid;Dietary Supplement: Siliphos+ Selenium - Methionine + Alpha Lipoic Acid;Drug: Metformin
|
| Outcome Measures: |
Impact on biochemical and echosonographic parametersIdentify changes in anthropometric parameters
|
| Sponsor/Collaborators: |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
|
| Gender: |
All
|
| Age: |
18 Years65 Years
|
| Phases: |
Phase 4
|
| Enrollment: |
50
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care
|
| Start Date: |
11/07/2012
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 February 2015
|
| Locations: |
Mexico
|
| URL: |
http://clinicaltrials.gov/show/NCT01650181
|
